Bicycle Therapeutics Plc ADR
(BCYC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 92,117 | 63,380 | 67,663 | N/A |
| Receivables | 7,145 | 11,313 | 3,001 | N/A |
| TOTAL | $104,146 | $76,769 | $71,512 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 2,292 | 1,818 | 1,362 | N/A |
| Other Non-Current Assets | 3,756 | 3,039 | 1,127 | 0 |
| TOTAL | $6,048 | $4,857 | $2,489 | $N/A |
| Total Assets | $110,194 | $81,626 | $74,001 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,949 | 1,887 | 2,065 | 0 |
| Accrued Expenses | 6,144 | 7,032 | 3,405 | N/A |
| TOTAL | $8,821 | $8,929 | $9,451 | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 728 | 10 | 3,981 | N/A |
| Other Non-Current Liabilities | 3,246 | 127,898 | 101,248 | 0 |
| TOTAL | $8,175 | $142,523 | $111,734 | $N/A |
| Total Liabilities | $16,996 | $151,452 | $121,185 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 17,995 | N/A | N/A | N/A |
| Common Shares | 227 | 10 | 5 | N/A |
| Retained earnings | -100,550 | -69,942 | -48,096 | N/A |
| Other shareholders' equity | -1,535 | -1,751 | 69 | 0 |
| TOTAL | $93,198 | $-69,826 | $-47,184 | $N/A |
| Total Liabilities And Equity | $110,194 | $81,626 | $74,001 | $0 |